在本届APACC 2023会议上,Schmidt博士带来了“WHO Long-Acting Guidelines in Asia”(WHO长效制剂指南在亚洲)的精彩报告,并在接受《感染医线》的现场采访中,进一步分享了WHO指南对长效制剂PrEP的推荐、亚洲执行WHO长效制剂指南面临的困难,以及亚洲在实现2030终结HIV流行方面仍需做出的努力。 01 《感染医线》:WHO 是如...
2024年更新版《WHO HIV暴露前预防实施工具:口服和长效PrEP的提供者模块》,为医疗机构提供暴露前预防(PrEP)提供了实用指导[8]。更新版整合了口服PrEP、达匹韦林阴道环和长效注射卡替拉韦的使用指南,包括个性化剂量、使用HIV自我检测、风险评估、当天PrEP以及在孕期和哺乳期的PrEP使用建议。此外,指南还指出了与提供PrEP相...
她热衷于改善公共卫生响应,以帮助终止HIV传播,尤其是引入和扩大PrEP和其他HIV生物医学预防方案。 在本届APACC 2023会议上,Schmidt博士带来了“WHO Long-Acting Guidelines in Asia”(WHO长效制剂指南在亚洲)的精彩报告,并在接受《感染医线》的现场采访中,进一步分享了WHO指南对长效制剂PrEP的推荐、亚洲执行WHO长效制剂指...
2024年更新版《WHO HIV暴露前预防实施工具:口服和长效PrEP的提供者模块》,为医疗机构提供暴露前预防(PrEP)提供了实用指导[8]。更新版整合了口服PrEP、达匹韦林阴道环和长效注射卡替拉韦的使用指南,包括个性化剂量、使用HIV自我检测、风险评估、当天PrEP以及在...
BACKGROUND\nPre-exposure prophylaxis (PrEP) has been implemented as a prevention against HIV; however, its impact on mental health, sexual and life satisfa... M Reiriz,B Rodríguez-Expósito,AJ Jiménez-García,... - 《Psicothema》 被引量: 0发表: 2023年 Sex in Chemsex: Sexual Response,...
Human immunodeficiency virus (HIV) testing presents a crucial entry point into HIV-related care such as pre-exposure prophylaxis (PrEP) initiation and HIV treatment. Globally, 21% of people living with HIV are still unaware of their serostatus [1]. Testing for HIV has improved in many settings...
Cooking Tips – 7 Helpful Cooking Guidelines To Help You For Amatuers Popular This Weekview all articles How To Transform Your Food Labeling Program With Prep-N-Print With Flex Food Foods or beverages consumed with apple cider vinegar to reduce the risk of kidney stones ...
womenBackground: US Centers for Disease Control and Prevention clinical guidelines for HIV pre-exposure prophylaxis (PrEP) are widely used to assess patients' PrEP eligibility. The guidelines include 2 versions of criteria-guidance summary criteria and recommended indications criteria-that diverge in a ...
°Schmidt博士:WHO长效制剂PrEP指南及亚洲终结... 感染医线 Schmidt博士:WHO长效制剂PrEP指南及亚洲终结HIV流行的优先事项丨UNA 在本届APACC 2023会议上,Schmidt博士带来了“WHO Long-Acting Guidelines in Asia”(WHO长效 û收藏 转发 评论 ñ赞 评论 o p 同时转发到我的微博 按热...
根据临床研究和示范性研究的报告,在接受口服PrEP时发生HIV感染的高危人群中,PrEP相关耐药率较低,而在未诊断的HIV感染急性期启动PrEP的人群中,耐药率会明显升高。 本次耐药报告总结了2020-2023年间发表的使用口服TDF+FTC方案的PrEP使用者的HIV耐药性研究结果。310例参与者在PrEP期间诊断出HIV感染且有基因型耐药检测结果...